124 related articles for article (PubMed ID: 35001789)
1. A model for predicting the overall survival of gastroenteropancreatic neuroendocrine neoplasms after surgery.
Feng LH; Su T; Lu Y; Ren S; Huang L; Qin X; Liao T
Scand J Gastroenterol; 2022 May; 57(5):581-588. PubMed ID: 35001789
[TBL] [Abstract][Full Text] [Related]
2. A nomogram incorporating treatment data for predicting overall survival in gastroenteropancreatic neuroendocrine tumors: a population-based cohort study.
Wu Z; Shang G; Zhang K; Wang W; Fan M; Lin R
Int J Surg; 2024 Apr; 110(4):2178-2186. PubMed ID: 38241384
[TBL] [Abstract][Full Text] [Related]
3. A Nomogram to Predict Individual Survival of Patients with Liver-Limited Metastases from Gastroenteropancreatic Neuroendocrine Neoplasms: A US Population-Based Cohort Analysis and Chinese Multicenter Cohort Validation Study.
Xu G; Xiao Y; Hu H; Jin B; Wu X; Wan X; Zheng Y; Xu H; Lu X; Sang X; Ge P; Mao Y; Cai J; Zhao H; Du S
Neuroendocrinology; 2022; 112(3):263-275. PubMed ID: 33902058
[TBL] [Abstract][Full Text] [Related]
4. Nomogram individually predicts the overall survival of patients with gastroenteropancreatic neuroendocrine neoplasms.
Fang C; Wang W; Feng X; Sun J; Zhang Y; Zeng Y; Wang J; Chen H; Cai M; Lin J; Chen M; Chen Y; Li Y; Li S; Chen J; Zhou Z
Br J Cancer; 2017 Nov; 117(10):1544-1550. PubMed ID: 28949958
[TBL] [Abstract][Full Text] [Related]
5. Development and validation of a nomogram for predicting the overall survival of patients with gastroenteropancreatic neuroendocrine neoplasms.
Xie S; Li L; Wang X; Li L
Medicine (Baltimore); 2021 Jan; 100(2):e24223. PubMed ID: 33466202
[TBL] [Abstract][Full Text] [Related]
6. Development and validation of a novel nomogram for predicting survival rate in pancreatic neuroendocrine neoplasms.
Liao T; Su T; Huang L; Li B; Feng LH
Scand J Gastroenterol; 2022 Jan; 57(1):85-90. PubMed ID: 34592854
[TBL] [Abstract][Full Text] [Related]
7. [Establishment and validation of a nomogram to predict overall survival of patients with gastric neuroendocrine neoplasms].
Wang YL; Guo Y; Zhang RH; Chen LH; Yang YJ; Wang W; Chen J; Zhou ZW
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Oct; 24(10):883-888. PubMed ID: 34674463
[No Abstract] [Full Text] [Related]
8. A prognostic nomogram based on log odds of positive lymph nodes to predict the overall survival in biliary neuroendocrine neoplasms (NENs) patients after surgery.
Jiang S; Yang F; Zhang L; Sang X; Lu X; Zheng Y; Xu Y
J Endocrinol Invest; 2022 Dec; 45(12):2341-2351. PubMed ID: 35908009
[TBL] [Abstract][Full Text] [Related]
9. Development and validation of nomogram combining serum biomarker for predicting survival in patients with resected rectal cancer.
Fan S; Li T; Zhou P; Peng Q; Zhu Y
Biosci Rep; 2019 Nov; 39(11):. PubMed ID: 31693739
[TBL] [Abstract][Full Text] [Related]
10. Development and validation of prognostic nomograms for patients with colon neuroendocrine neoplasms.
Xu R; Zhou B; Hu P; Xue B; Gu D; Li X; Tang Q
World J Surg Oncol; 2021 Aug; 19(1):233. PubMed ID: 34364382
[TBL] [Abstract][Full Text] [Related]
11. Development and Validation of a Nomogram-Based Prognostic Evaluation Model for Sarcomatoid Hepatocellular Carcinoma.
Ge D; Luo Z; Mao R; Zhao H; Lv X; Zhao J; Zhou J; Huang Z; Zhang Y; Li Z; Bi X; Cai J
Adv Ther; 2020 Jul; 37(7):3185-3205. PubMed ID: 32436026
[TBL] [Abstract][Full Text] [Related]
12. Development and external validation of a nomogram predicting overall survival after curative resection of colon cancer.
Wang S; Liu Y; Shi Y; Guan J; Liu M; Wang W
J Int Med Res; 2021 May; 49(5):3000605211015023. PubMed ID: 33990147
[TBL] [Abstract][Full Text] [Related]
13. Development and validation of a novel nomogram for postoperative overall survival of patients with primary gastric signet-ring cell carcinoma: a population study based on SEER database.
Nie D; Zheng H; An G; Li J
J Cancer Res Clin Oncol; 2023 Sep; 149(11):8593-8603. PubMed ID: 37097391
[TBL] [Abstract][Full Text] [Related]
14. Epidemiologic Trends of and Factors Associated With Overall Survival for Patients With Gastroenteropancreatic Neuroendocrine Tumors in the United States.
Xu Z; Wang L; Dai S; Chen M; Li F; Sun J; Luo F
JAMA Netw Open; 2021 Sep; 4(9):e2124750. PubMed ID: 34554237
[TBL] [Abstract][Full Text] [Related]
15. Establishment and Verification of a Nomogram for Predicting Survival in Patients with Small Intestinal Gastrointestinal Stromal Tumors.
Lu G; Li J; Wu L; Shi Y; Zhang X; Xia Y; Li L
Dig Dis; 2022; 40(1):50-61. PubMed ID: 33752202
[TBL] [Abstract][Full Text] [Related]
16. Risk factors, prognostic factors, and nomograms for distant metastases in patients with gastroenteropancreatic neuroendocrine tumors: a population-based study.
Li X; Fan Y; Tong J; Lou M
Front Endocrinol (Lausanne); 2024; 15():1264952. PubMed ID: 38449852
[TBL] [Abstract][Full Text] [Related]
17. Prognostic nomogram predicts overall survival in pulmonary large cell neuroendocrine carcinoma.
He Y; Liu H; Wang S; Chen Y
PLoS One; 2019; 14(9):e0223275. PubMed ID: 31560723
[TBL] [Abstract][Full Text] [Related]
18. Development and validation of a nomogram to predict overall survival for patients with metastatic renal cell carcinoma.
Zheng W; Zhu W; Yu S; Li K; Ding Y; Wu Q; Tang Q; Zhao Q; Lu C; Guo C
BMC Cancer; 2020 Nov; 20(1):1066. PubMed ID: 33148204
[TBL] [Abstract][Full Text] [Related]
19. Development and validation of a nomogram to individually predict survival of young patients with nonmetastatic gastric cancer: A retrospective cohort study.
Wu C; Wang N; Zhou H; Wang T; Zhao D
Saudi J Gastroenterol; 2019; 25(4):236-244. PubMed ID: 30719999
[TBL] [Abstract][Full Text] [Related]
20. A nomogram for individualized estimation of survival among adult patients with adrenocortical carcinoma after surgery: a retrospective analysis and multicenter validation study.
Kong J; Zheng J; Cai J; Wu S; Diao X; Xie W; Chen X; Liao C; Yu H; Fan X; Huang C; Liu Z; Chen W; Lv Q; Qin H; Huang J; Lin T
Cancer Commun (Lond); 2019 Nov; 39(1):80. PubMed ID: 31775884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
